Case Study: MDX Labs accelerates multi-discipline lab growth with CrelioHealth LIS

Catering To Diverse Business Models Using A Single LIS

MDX Labs, a fast-growing lab founded in late 2021, needed a lab information system that could keep up as it expanded beyond COVID-19 testing into new disciplines like toxicology, hematology, clinical chemistry, pathology, and molecular diagnostics. Its previous LIS could only support the COVID-19 modality, lacked dedicated toxicology workflows and training support, and made analyzer integration, reporting, and supply chain management difficult for a small team operating under heavy demand. CrelioHealth’s Crelio LIS was chosen to replace the old system and support this rapid expansion.

With CrelioHealth, MDX Labs gained dedicated modality-based workflows, smoother analyzer and doctor-office integrations, automated reporting and order management, and tools to manage diverse B2B and non-traditional business models from clinics and hospitals to prisons and rehabilitation centers. The implementation was completed quickly, with the CrelioHealth team keeping pace with MDX Labs’ needs despite limited manpower, and the customer reported that the platform helped them expand at the rate they wanted while reducing manual effort and improving responsiveness across operations.

MDX Labs

Jason Saylor

Director of Business Development